학술논문
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers
Document Type
Article
Author
Source
In Vaccine August 2023
Subject
Language
ISSN
0264-410X